Cargando…
Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications
BACKGROUND: Herein we investigate the difference between Kawasaki disease (KD) with and without a recent history of SARS-CoV-2 infection. METHODS: We compared the clinical characteristics of patients with KD during the SARS-CoV-2 pandemic in a single children's hospital in Korea. Fifty-two pati...
Autores principales: | Roh, Da Eun, Lim, Young Tae, Kwon, Jung Eun, Kim, Yeo Hyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714663/ https://www.ncbi.nlm.nih.gov/pubmed/36467487 http://dx.doi.org/10.3389/fped.2022.1036306 |
Ejemplares similares
-
The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid
por: Kwon, Jung Eun, et al.
Publicado: (2020) -
Bacille Calmette-Guérin Site Reactivation of Kawasaki Disease in Infants under 3 Months of Age: Relation with Diagnosis and Prognosis
por: Roh, Da Eun, et al.
Publicado: (2022) -
Importance of Serum Ferritin Level for Early Diagnosis and Differentiation in Patients with Kawasaki Disease with Macrophage Activation Syndrome
por: Roh, Da Eun, et al.
Publicado: (2021) -
SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association
por: Cazzaniga, Marco, et al.
Publicado: (2020) -
Spontaneous defervescence and its prediction in the acute phase of Kawasaki disease
por: Shin, Eun Jung, et al.
Publicado: (2022)